News | January 29, 2008

Iroko Acquires Rights to Merck Drug for PTCA Patients

January 30, 2008 - Iroko Pharmaceuticals (Iroko) acquired all non-U.S. commercial rights to Aggrastat (tirofiban HCl) from Merck & Co. Inc., used for patients undergoing coronary angioplasty or atherectomy to prevent cardiac ischemic complications, in a move Iroko hopes will strengthen its presence in the cardiovascular market.

Outside of the U.S. market, Aggrastat in combination with heparin is indicated for patients with unstable angina or non-Q wave myocardial infarction to prevent cardiac ischemic events, and is also indicated for patients with coronary ischemic syndromes undergoing coronary angioplasty or atherectomy to prevent cardiac ischemic complications related to abrupt closure of the treated coronary artery. Aggrastat is indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing percutaneous transluminal coronary angioplasty (PTCA).

"We are very pleased to conclude another transaction with Merck by acquiring this patent-protected asset," stated Osagie Imasogie, Iroko's chairman and senior managing partner of Phoenix IP Ventures. "Aggrastat substantially builds on Iroko's presence in the cardiovascular space and leverages our existing worldwide capabilities and infrastructure. This transaction is consistent with our strategy of growing Iroko through targeted asset acquisitions. We are pleased that, with the acquisition of Aggrastat, Iroko's annual revenues will achieve a major milestone by exceeding $100 million dollars on a most recent year basis."

For more information: www.iroko.com and www.merck.com

Related Content

Stryker Sustainability Solutions, Angiodynamics Soft Vu Omni Flush Angiographic Catheters, recall
News | Angiographic Catheter | July 25, 2016
Stryker Sustainability Solutions (formerly Ascent Healthcare Solutions) is recalling Angiodynamics Soft Vu Omni Flush...
Cook Medical, expanded recall, October 2015, Beacon Tip Angiographic Catheters

Image courtesy of Cook Medical

News | Angiographic Catheter | October 14, 2015
On Oct. 7, 2015, Cook Medical initiated a voluntary recall for select sizes of Beacon Tip Angiographic Catheters. This...
Cook Medical, global recall, beacon tip angiographic catheters, FDA
News | Angiographic Catheter | August 11, 2015
On July 2, Cook Medical initiated a voluntary recall of 2,239 lots of beacon tip angiographic catheters. A total of 95,...
Overlay Init